je.st
news
Embrace Low-Cap Biotech For High Gains: Eden Rahim Of Next Edge Capital
2016-03-03 17:14:01| Biotech - Topix.net
Biotech is a slow-growth world, but if you can show good organic growth, the market will eventually pay up. Eden Rahim of Toronto-based Next Edge Capital has had his share of multibagger and grand-slam successes, and is one of the few mutual fund managers who feels comfortable investing in micro-cap biotech names side-by-side with billion-dollar biotech stocks.
Tags: high
capital
edge
gains
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||